Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation.
Chien Y, Chien CS, Chiang HC, Huang WL, Chou SJ, Chang WC, Chang YL, Leu HB, Chen KH, Wang KL, Lai YH, Liu YY, Lu KH, Li HY, Sung YJ, Jong YJ, Chen YJ, Chen CH, Yu WC.
Chien Y, et al. Among authors: chen yj, chen ch, chen kh.
Oncotarget. 2016 Dec 27;7(52):87161-87179. doi: 10.18632/oncotarget.13552.
Oncotarget. 2016.
PMID: 27888626
Free PMC article.